Immunotherapy in locally advanced head and neck squamous cell carcinoma: The current status and future outlook.

Head and neck squamous cell carcinoma presents a significant global health burden, with the majority of cases diagnosed at a locally advanced stage requiring multimodal therapy. While the immune checkpoint inhibitors have transformed outcomes in the…

Preview only. Read the full abstract at the source